A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
Clinical trial NCT00253227 · COMPLETED
Trial details
- NCT number
- NCT00253227
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-07-01
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.